Longterm oral or parenteral CST (PMID 11239846) poses the risk of opportunistic pulmonary (PMID 20736243, 2817582) and/or systemic infections (PMID 23982055). Continued attention is required as the use of costicosteroids may be increasing (PMID 21393338)

Last update : 20/01/2015
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar hemorrhage
IV - Airway involvement
VI - Pulmonary vasculopathies
VII - Mediastinal involvement
VIII - Central-large-upper airway (incl pharyngeal-nasal) involvement
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XI - Miscellaneous
XII - Cardiovascular involvement / toxicity
XVI - Imaging
XVII - Infections & related conditions